After observing such a striking Nrf2 and AKR1C1 expression pattern in partial and non-responding endometrial samples, we sought to investigate if these two molecules may contribute to progestin resistance in endometrial cancer. This evidence concerns the gene AKR1C1 and endometrial cancer.